Patricia L. Kavanagh, MD

Associate Professor, Pediatrics

Patricia Kavanagh
88 E. Newton St Vose Hall


Dr. Kavanagh has a national reputation in using systems approaches to improve the care of children and adults with sickle cell disease (SCD) in the emergency department setting. As an attending physician in the BMC Pediatric ED, she and colleagues defined and refined treatment standards for children with sickle cell disease. She has similarly worked to improve care for adults with sickle cell disease in the ED through guideline-based care pathways and the use of individualized pain protocols. Her current grant activities include studying the impact of screening and referring families with unmet basic needs on health on outcomes for children with sickle cell disease, and serving as a subject matter expert in a multisite randomized trial comparing individualized pain plans with weight-based protocols. Nationally she co-founded and serves as Chair of the Emergency Department Sickle Cell Care Coalition, and serves on the Oversight Steering Committee of HRSA’s Sickle Cell Disease Treatment Demonstration Program and the Steering Committee for the American Society of Hematology’s Sickle Cell Disease Coalition. She completed her pediatrics residency at Boston Children’s Hospital and Boston Medical Center, and a fellowship in General Academic Pediatrics at Chobanian and Avedisian School of Medicine/Boston Medical Center.

Other Positions

  • Member, Center of Excellence in Sickle Cell Disease, Boston University


  • Boston University, MD
  • Boston University, BS
  • Boston University, BA


  • Published on 7/5/2022

    Kavanagh PL, Fasipe TA, Wun T. Sickle Cell Disease: A Review. JAMA. 2022 07 05; 328(1):57-68. PMID: 35788790.

    Read at: PubMed
  • Published on 3/18/2021

    Kavanagh PL, Frater F, Navarro T, LaVita P, Parrish R, Iorio A. Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers. J Am Med Inform Assoc. 2021 03 18; 28(4):766-771. PMID: 33484123.

    Read at: PubMed
  • Published on 1/12/2021

    Loo S, Brochier A, Wexler MG, Long K, Kavanagh PL, Garg A, Drainoni ML. Addressing unmet basic needs for children with sickle cell disease in the United States: clinic and staff perspectives. BMC Health Serv Res. 2021 Jan 12; 21(1):55. PMID: 33435984.

    Read at: PubMed
  • Published on 12/28/2020

    Ibemere SO, Dubbs SB, Barnhart HX, Brown JL, Freiermuth CE, Kavanagh P, Paice JA, Strouse JJ, Wilkerson RG, Tanabe P. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE). Contemp Clin Trials. 2021 02; 101:106252. PMID: 33348066.

    Read at: PubMed
  • Published on 9/1/2020

    Kavanagh PL, Hirshon JM. EDSC3: Working to Improve Emergency Department Care of Individuals With Sickle Cell Disease. Ann Emerg Med. 2020 09; 76(3S):S80-S82. PMID: 32928468.

    Read at: PubMed
  • Published on 8/1/2020

    Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM. Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care. J Pediatr Hematol Oncol. 2020 08; 42(6):412-413. PMID: 32404689.

    Read at: PubMed
  • Published on 7/8/2020

    Faro EZ, Shook L, Treadwell MJ, King AA, Whiteman LN, Ivy ED, Hulihan M, Kavanagh PL, Selk S, Oyeku S, Berns SD. A National Measurement Framework to Assess and Improve Sickle Cell Care in 4 US Regions. Public Health Rep. 2020 Jul/Aug; 135(4):442-451. PMID: 32639897.

    Read at: PubMed
  • Published on 2/19/2020

    Gutman CK, Dorfman D, Meese H, Kavanagh P, Koyama A. Identifying a Golden Opportunity: Adolescent Interest in Contraceptive Initiation in a Pediatric Emergency Department. J Womens Health (Larchmt). 2020 05; 29(5):622-626. PMID: 32074475.

    Read at: PubMed
  • Published on 2/28/2019

    Melita N, Diaz-Linhart Y, Kavanagh PL, Sobota A. Developing a Problem-solving Intervention to Improve Self-Management and Transition Readiness in Adolescents with Sickle Cell Disease. J Pediatr Nurs. 2019 May - Jun; 46:26-32. PMID: 30826724.

    Read at: PubMed
  • Published on 5/17/2018

    Akinsola B, Hagbom R, Zmitrovich A, Kavanagh PL, Ashkouti A, Simon HK, Fleming A, Jain S, Dampier C, Morris CR. Impact of Intranasal Fentanyl in Nurse Initiated Protocols for Sickle Cell Vaso-occlusive Pain Episodes in a Pediatric Emergency Department. Am J Hematol. 2018 May 17. PMID: 29770479.

    Read at: PubMed

View 18 more publications: View full profile at BUMC

View all profiles